Buscar
01/12/2025
Custom-made dynamic 3-dimensional-printed prostheses for chest wall reconstruction: A multicenter study
Cano, JR, Jiménez, U, Trujillo, JC, Galbis, JM, Monopoli, D, Pérez, D, Fra-Fernández, S, Uribe-Etxebarria, N, Martínez E., Estors, M, Mentado, B, Muñoz-Molina, GM, Medina, R, Lorenzo, M, Hernandez-Ferrandez, J, Tavárez, W, Leung, M, Moreno-Mata, N. Custom-made dynamic 3-dimensional-printed prostheses for chest wall reconstruction: A multicenter study. Jtcvs Techniques. 2025; 34DOI:10.1016/j.xjtc.2025.09.010. PMID:41368406. IF:(Q/D).
01/12/2025
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy
Torrent, A, Morgades, M, Iacoboni, G, Reguera, JL, Kwon, M, Corral, LL, Hernani, R, Ortiz-Maldonado, V, Sanz, J, Gonzalez, ACC, Guerra, L, Pina, JMS, Mussetti, A, Garcia-Sancho, AM, Bastos-Oreiro, M, Delgado, J, Carpio, C, Sancho, JM, Perez-Martinez, A, Barba, P. Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy. BONE MARROW TRANSPLANTATION. 2025; 60(12)DOI:10.1038/s41409-025-02722-y. PMID:41028300. IF:5.200(Q1/1D).
01/12/2025
Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
Canelo-Aybar, C, Alonso-Coello, P, Muratov, S, Tarride, JE, Dimitrova, N, Giusti, F, Borisch, B, Castells, X, Duffy, SW, Fitzpatrick, P, Follmann, M, Giordano, L, Hofvind, S, Lebeau, A, Quinn, C, Torresin, A, Rossi, PG, Schünemann, H, Nyström, L, Broeders, M. Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality. BREAST. 2025; 84DOI:10.1016/j.breast.2025.104621. PMID:41202390. IF:7.900(Q1/1D).
01/12/2025
Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol
Casares, LD, Pereiro, JE, Fernández, MTT, García, XC, Millet, JP, Solchaga, VP, Elorza, EN, García, JT, de Santiago, AD, Márquez, RL, Gallardo, JFM, Galán, VG, Alonso, MM, Brusola, AG, Rey, RR, García, LA, Herrero, FS, Serrano, RG, Fullola, MG, Díez, MT, Zanon, TT, Portero, MF, García, PA, Lopez, AMS, Aznar, ML, Camprecios, JM, Saborit, N, Montalvá, AS. Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Bmj Open Respiratory Research. 2025; 12(1)DOI:10.1136/bmjresp-2024-002475. PMID:41360613. IF:3.400(Q2/3D).